RGS10与RGS18差异性地限制血小板活化、促进血小板生成并延长血小板存活
研究探讨血小板中两种最丰富的RGS蛋白RGS10和RGS18的联合作用。双基因敲除小鼠出现血小板计数降低40%、存活缩短、基础TREM样转录本1表达升高、对凝血酶受体激活肽剂量反应曲线左移、对ADP和TxA2最大反应增强,以及体内穿透性损伤反应大幅加剧;单一敲除均不表现此组合表型。三种小鼠巨核细胞数量和倍体正常,但RGS18-/-和RGS10-/-18-/-小鼠从严重急性血小板减少中恢复较慢。
要点
- RGS10与RGS18在血小板中具有互补作用,同时缺失才显现完整调控表型
- 双敲除小鼠血小板计数降低40%,可被阿司匹林和P2Y12拮抗剂部分逆转
- RGS18-/-小鼠血小板计数降低15%,不受抗血小板药物影响,血小板存活正常
核心结论
- RGS10和RGS18在血小板中具有互补作用,同时去除两者揭示了该调控机制在体内控制血小板反应性、调节止血反应、促进血小板生成和延长血小板存活的程度。
研究设计与样本
- 研究使用缺失RGS10、RGS18或同时缺失两者的三种小鼠品系,比较其血小板表型。
主要发现
- 双敲除小鼠血小板计数降低40%,血小板存活缩短,该降低可被阿司匹林和P2Y12拮抗剂部分逆转。
- 双敲除小鼠血小板基础TREM样转录本1表达升高,对凝血酶受体激活肽的剂量反应曲线左移,对ADP和TxA2的最大反应增强,体内对穿透性损伤的反应大幅加剧。
- RGS10-/-血小板体外对激动剂反应增强,但血小板计数和存活正常。
- RGS18-/-小鼠血小板计数降低15%,不受抗血小板药物影响,对血小板激动剂反应接近正常,血小板存活正常。
- 三种小鼠品系巨核细胞数量和倍体正常,但RGS18-/-和RGS10-/-18-/-小鼠从严重急性血小板减少中恢复较慢。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
G protein-coupled receptors are critical mediators of platelet activation whose signaling can be modulated by members of the regulator of G protein signaling (RGS) family. The 2 most abundant RGS proteins in human and mouse platelets are RGS10 and RGS18. While each has been studied individually, critical questions remain about the overall impact of this mode of regulation in platelets. Here, we report that mice missing both proteins show reduced platelet survival and a 40% decrease in platelet count that can be partially reversed with aspirin and a P2Y12 antagonist. Their platelets have increased basal (TREM)-like transcript-1 expression, a leftward shift in the dose/response for a thrombin receptor-activating peptide, an increased maximum response to adenosine 5'-diphosphate and TxA2, and a greatly exaggerated response to penetrating injuries in vivo. Neither of the individual knockouts displays this constellation of findings. RGS10-/- platelets have an enhanced response to agonists in vitro, but platelet count and survival are normal. RGS18-/- mice have a 15% reduction in platelet count that is not affected by antiplatelet agents, nearly normal responses to platelet agonists, and normal platelet survival. Megakaryocyte number and ploidy are normal in all 3 mouse lines, but platelet recovery from severe acute thrombocytopenia is slower in RGS18-/- and RGS10-/-18-/- mice. Collectively, these results show that RGS10 and RGS18 have complementary roles in platelets. Removing both at the same time discloses the extent to which this regulatory mechanism normally controls platelet reactivity in vivo, modulates the hemostatic response to injury, promotes platelet production, and prolongs platelet survival.
引用
- DeHelian D, Gupta S, Wu J, et al. RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survival. Blood. 2020. PMID: 32542378. doi:10.1182/blood.2019003251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。